ATE225174T1 - Selbstemulgierende formulierung enthaltend saure lipophile verbindungen - Google Patents

Selbstemulgierende formulierung enthaltend saure lipophile verbindungen

Info

Publication number
ATE225174T1
ATE225174T1 AT98936888T AT98936888T ATE225174T1 AT E225174 T1 ATE225174 T1 AT E225174T1 AT 98936888 T AT98936888 T AT 98936888T AT 98936888 T AT98936888 T AT 98936888T AT E225174 T1 ATE225174 T1 AT E225174T1
Authority
AT
Austria
Prior art keywords
self
emulsifying formulation
pharmaceutically acceptable
formulation containing
containing acidic
Prior art date
Application number
AT98936888T
Other languages
English (en)
Inventor
Walter Morozowich
Ping Gao
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE225174T1 publication Critical patent/ATE225174T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
AT98936888T 1997-07-29 1998-07-27 Selbstemulgierende formulierung enthaltend saure lipophile verbindungen ATE225174T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5401297P 1997-07-29 1997-07-29
PCT/US1998/014817 WO1999006044A1 (en) 1997-07-29 1998-07-27 Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation

Publications (1)

Publication Number Publication Date
ATE225174T1 true ATE225174T1 (de) 2002-10-15

Family

ID=21988155

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98936888T ATE225174T1 (de) 1997-07-29 1998-07-27 Selbstemulgierende formulierung enthaltend saure lipophile verbindungen

Country Status (24)

Country Link
US (1) US6231887B1 (de)
EP (1) EP0989851B1 (de)
JP (1) JP4524367B2 (de)
KR (1) KR100509131B1 (de)
CN (1) CN1112927C (de)
AT (1) ATE225174T1 (de)
AU (1) AU728626B2 (de)
BR (1) BR9810729B1 (de)
CA (1) CA2294033C (de)
CY (1) CY2006002I2 (de)
CZ (1) CZ296957B6 (de)
DE (1) DE69808463T2 (de)
DK (1) DK0989851T3 (de)
ES (1) ES2184310T3 (de)
FI (1) FI20000172A7 (de)
HU (1) HU228923B1 (de)
NO (1) NO323425B1 (de)
NZ (1) NZ502566A (de)
PL (1) PL192865B1 (de)
PT (1) PT989851E (de)
RU (1) RU2202346C2 (de)
SI (1) SI0989851T1 (de)
SK (1) SK284616B6 (de)
WO (1) WO1999006044A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6956048B2 (en) 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
ES2234582T3 (es) * 1999-03-31 2005-07-01 PHARMACIA & UPJOHN COMPANY LLC Emulsiones farmaceuticas para inhibidores de proteasas retrovirales.
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0000774D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
UA78689C2 (en) 2000-10-31 2007-04-25 Boehringer Ingelheim Pharma Pyranone-based pharmaceutical composition (variants)
SE0102993D0 (sv) * 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
US20030165545A1 (en) * 2002-01-30 2003-09-04 Allergan, Inc. Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same
JP2005523262A (ja) * 2002-02-01 2005-08-04 ファイザー・プロダクツ・インク 薬物及び親油性ミクロ相形成物質の非晶質分散物の医薬組成物
US6828301B2 (en) * 2002-02-07 2004-12-07 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for hepatitis C viral protease inhibitors
US20040191332A1 (en) * 2003-03-27 2004-09-30 Allergan, Inc. Preserved ophthalmic compositions
WO2004093915A1 (en) * 2003-04-02 2004-11-04 Boehringer Ingelheim International, Gmbh Pharmaceutical compositions for hepatitis c viral protease inhibitors
ATE540671T1 (de) 2003-08-04 2012-01-15 Bend Res Inc Pharmazeutische zusammensetzungen von adsorbaten von amorphen arzneimitteln und lipophilen mikrophasen-bildenden materialien
EP1672985A1 (de) * 2003-10-07 2006-06-28 Eli Lilly And Company Flüssige ractopamin-formulierungen
JP2008520701A (ja) * 2004-11-19 2008-06-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング チプラナビル及びレバーセットの同時投与を介したｈｉｖ感染症の治療方法
WO2006055660A2 (en) * 2004-11-19 2006-05-26 Boehringer Ingelheim International Gmbh Method for treating hiv infection through co-administration of tipranavir and uk-427, 857
WO2006060159A1 (en) * 2004-12-01 2006-06-08 Boehringer Ingelheim International Gmbh Method for treating hiv infection through co-administration of tipranavir and gw695634
JP5028885B2 (ja) * 2006-07-04 2012-09-19 大正製薬株式会社 ユビデカレノン含有自己乳化組成物
WO2008112289A2 (en) 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-protease inhibitor conjugates
WO2009114151A1 (en) * 2008-03-12 2009-09-17 Nektar Therapeutics Oligomer-amino acid and olgomer-atazanavir conjugates
JP2012530069A (ja) 2009-06-12 2012-11-29 ネクター セラピューティックス プロテアーゼ阻害剤、水溶性非ペプチドオリゴマーおよび親油性部分を含む共有結合体
CN102470103B (zh) * 2009-07-07 2016-09-07 贝林格尔.英格海姆国际有限公司 用作丙型肝炎病毒蛋白酶抑制剂的药物组合物
EP2488022B1 (de) 2009-10-16 2018-01-10 Mochida Pharmaceutical Co., Ltd. Zusammensetzungen
RU2419426C1 (ru) * 2010-04-26 2011-05-27 Всеволод Иванович Киселев Лекарственное средство на основе дииндолилметана (dim) с повышенной биодоступностью и его использование в лечении гиперпластических и воспалительных заболеваний человека
SG185389A1 (en) 2010-05-03 2012-12-28 Teikoku Pharma Usa Inc Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
JP6474732B2 (ja) * 2013-01-14 2019-02-27 インファースト ヘルスケア リミテッド 激痛治療用組成物と方法
AU2016226224B2 (en) * 2015-03-05 2021-07-08 Allergan, Inc. Self-emulsifying drug delivery system (SEDDS) for ophthalmic drug delivery

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230702A (en) 1978-01-09 1980-10-28 Kali-Chemie Pharma Gmbh Readily enterally absorbable pharmaceutical compositions of per se poorly enterally absorbable pharmacologically active agents
DE3300793A1 (de) * 1983-01-12 1984-07-12 Bayer Ag, 5090 Leverkusen Coccidiosemittel
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
US5071643A (en) 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
IL102236A0 (en) * 1991-06-27 1993-01-14 Ltt Inst Co Ltd Topical preparations containing cyclosporin
GB9113872D0 (en) 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
GB9208712D0 (en) * 1992-04-22 1992-06-10 Sandoz Ltd Pharmaceutical compositions containing cyclosporin derivates
US5376688A (en) 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
CA2195623A1 (en) * 1994-07-22 1996-02-08 Rajeev D. Gokhale Self-emulsifying drug delivery system
JPH11504028A (ja) * 1995-04-24 1999-04-06 イースム リサーチ ディベロップメント カンパニー オブ ザ ヒーブル ユニバーシティ オブ エルサレム 油／水エマルジョンを作り出す自己乳化性配合物
CZ292192B6 (cs) 1995-06-06 2003-08-13 F. Hoffmann-La Roche Ag Jednotková dávka farmaceutického prostředku, který je inhibitorem proteinázy
ZA9710071B (en) * 1996-11-21 1998-05-25 Abbott Lab Pharmaceutical composition.

Also Published As

Publication number Publication date
CY2006002I1 (el) 2011-02-02
HUP0002440A2 (hu) 2001-09-28
FI20000172L (fi) 2000-01-28
SI0989851T1 (en) 2003-04-30
RU2202346C2 (ru) 2003-04-20
HUP0002440A3 (en) 2001-10-29
CN1112927C (zh) 2003-07-02
JP2002510330A (ja) 2002-04-02
DE69808463T2 (de) 2003-06-26
NZ502566A (en) 2002-03-28
PL192865B1 (pl) 2006-12-29
BR9810729A (pt) 2000-08-08
WO1999006044A1 (en) 1999-02-11
NO20000466D0 (no) 2000-01-28
US6231887B1 (en) 2001-05-15
BR9810729B1 (pt) 2010-07-13
CA2294033A1 (en) 1999-02-11
CN1261796A (zh) 2000-08-02
DK0989851T3 (da) 2003-01-27
PL338335A1 (en) 2000-10-23
SK162000A3 (en) 2000-12-11
AU8573898A (en) 1999-02-22
ES2184310T3 (es) 2003-04-01
KR100509131B1 (ko) 2005-08-18
EP0989851A1 (de) 2000-04-05
HK1028879A1 (en) 2001-03-09
JP4524367B2 (ja) 2010-08-18
PT989851E (pt) 2002-12-31
NO20000466L (no) 2000-03-28
EP0989851B1 (de) 2002-10-02
FI20000172A7 (fi) 2000-01-28
CZ2000156A3 (cs) 2000-05-17
SK284616B6 (sk) 2005-07-01
DE69808463D1 (de) 2002-11-07
NO323425B1 (no) 2007-04-30
AU728626B2 (en) 2001-01-11
CZ296957B6 (cs) 2006-08-16
CY2006002I2 (el) 2012-01-25
KR20010022369A (ko) 2001-03-15
HU228923B1 (en) 2013-06-28
CA2294033C (en) 2007-01-09

Similar Documents

Publication Publication Date Title
ATE225174T1 (de) Selbstemulgierende formulierung enthaltend saure lipophile verbindungen
DE60019693D1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
IT1281337B1 (it) Preparazione farmaceutica orale contenente ciclosporina come sostanza attiva ed un preconcentrato di emulsione multipla
HUP0301972A2 (hu) Fentanilszerű szerkezetű opioidot és ketamint tartalmazó hatóanyag-kombináció és ezt tartalmazó gyógyszerkészítmény
YU21803A (sh) Farmaceutski aktivni derivati sulfonamida koji imaju i lipofilne i jonizujuće osobine kao inhibitori protein-junkinaza
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
ZA200410109B (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability.
PT999838E (pt) Formulacao auto-emulsionante para compostos lipofilicos
BRPI0116237B8 (pt) "composto de sulfamida, composição farmacêutica contendo o mesmo e seu uso como medicamento antagonista de receptor de endotelina".
IL149163A0 (en) Piperazine derivatives of carbazole, their preparation and pharmaceutical compositions containing them
EP0882450A3 (de) Cholesterinsenkende Zusammensetzung enthaltend Coenzym Q
IL151172A0 (en) Amine derivatives, their preparation and use as bax modulators
ATE321543T1 (de) Pharmazeutische zusammensetzungen mit hydroximsäurederivaten
DK1303258T3 (da) Hidtil ukendte aerosolformuleringer, der indeholder et polært, floureret molekyle
EP1193256A8 (de) Pharmazeutisch aktive Benzolsulfonamidderivate als JNK-Proteininhibitoren
IL162496A0 (en) Pharmaceutical compositions containing cyclosporin
IL148874A0 (en) Sulfonyl amino acid derivatives, their preparation and pharmaceutical compositions containing them
HUP0004701A2 (hu) Új dezloratadin sók, az ezeket tartalmazó gyógyászati készítmények és eljárás azok előállítására
NO950177D0 (no) Farmakologisk aktive erivater
IT1291278B1 (it) Preparazione farmaceutica a base di nimesulide per uso topico
EA200000261A2 (ru) Новые замещенные димерные соединения, способ их получения и содержащая их фармацевтическая композиция
DE60017720D1 (de) Pharmazeutische emulsionen für retroviral-protease hemmende verbindungen
ATE298564T1 (de) Arzneimittelformulierung enthaltend einen ltb4 antagonisten und einen netzmittel
TH77238A (th) สารสูตรผสมที่คล้ายกับไซโคลสปอริน